Structure |
Chemical Name |
CAS |
MF |
![SalMeterol EP IMpurity D](../cas/20130318/gif/cb42622471.gif) |
SalMeterol EP IMpurity D |
1391052-04-2 |
C34H47NO7 |
![3-Pyridinecarboxylic Acid 2-AMinoethyl Ester Dihydrochloride](../cas/gif/87330-70-9.gif) |
3-Pyridinecarboxylic Acid 2-AMinoethyl Ester Dihydrochloride |
87330-70-9 |
C8H11ClN2O2 |
![PeMetrexed EP IMpurity D](../cas/20210111/gif/144051-68-3.gif) |
PeMetrexed EP IMpurity D |
144051-68-3 |
C25H28N6O9 |
![SuMatriptan EP IMpurity F](../cas/20150408/gif/cb42630490.gif) |
SuMatriptan EP IMpurity F |
2074615-63-5 |
C13H17N3O2S |
![2-[[(5-hydroxy-1H-benziMidazol-2-yl)sulfinyl]Methyl]-3,5-diMethyl-1-4(1H)-pyridone](../cas/20150408/gif/cb42645155.gif) |
2-[[(5-hydroxy-1H-benziMidazol-2-yl)sulfinyl]Methyl]-3,5-diMethyl-1-4(1H)-pyridone |
|
C15H15N3O3S |
![Perindopril Impurity](../) |
Perindopril Impurity |
|
|
![4-Acetoxyisophthalic Acid](../cas/20130318/gif/cb42647548.gif) |
4-Acetoxyisophthalic Acid |
5985-26-2 |
C10H8O6 |
![Ganciclovir Dipropionate](../cas/20150408/gif/86357-2d20-2.gif) |
Ganciclovir Dipropionate |
86357-20-2 |
C15H21N5O6 |
![IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide](../cas/20150408/gif/39084-88-3.gif) |
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide |
39084-88-3 |
C10H11Cl2NO |
![1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione](../cas/gif/61919-52-6.gif) |
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione |
61919-52-6 |
C20H26O3 |
![5-Fluoro ent-LaMivudine Acid D-Menthol Ester](../cas/gif/764659-79-2.gif) |
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
![Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride](../cas/20150408/gif/15210-60-3.gif) |
Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride |
15210-60-3 |
C13H24ClN |
![3-((butyryloxy)Methyl) 5-Methyl 4-(2',3'-dichlorophenyl)-2,6-diMethylpyridine-3,5-dicarboxylate](../cas/20150408/gif/188649-48-1.gif) |
3-((butyryloxy)Methyl) 5-Methyl 4-(2',3'-dichlorophenyl)-2,6-diMethylpyridine-3,5-dicarboxylate |
188649-48-1 |
C21H21Cl2NO6 |
![Bis Valacyclovir (~90%)](../cas/gif/1356019-51-6.gif) |
Bis Valacyclovir (~90%) |
1356019-51-6 |
C27H40N12O8 |
![Flupirtine DiMer](../cas/20180808/gif/1417916-52-9.gif) |
Flupirtine DiMer |
1417916-52-9 |
C30H32F2N8O4 |
![(S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one](../cas/20150408/gif/327623-36-9.gif) |
(S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one |
327623-36-9 |
C21H19F6NO3 |
![3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide](../cas/20150408/gif/cb42658629.gif) |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
2304623-36-5 |
C16H14N2O3S |
![EsoMeprazole iMpurity](../cas/20211123/gif/1424857-86-2.gif) |
EsoMeprazole iMpurity |
1424857-86-2 |
C11H15NO3 |
![AMoxicillin iMpurity L](../cas/20150408/gif/cb42665520.gif) |
AMoxicillin iMpurity L |
|
C16H19N3O5S |
![Azilsartan iMpurity G](../) |
Azilsartan iMpurity G |
|
|
![(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine](../cas/20150408/gif/253337-60-9.gif) |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine |
253337-60-9 |
C22H25N |
![3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide](../cas/20150408/gif/cb42666835.gif) |
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide |
1675248-19-7 |
C16H22N6O2 |
![Blonanserin iMpurity](../cas/20180808/gif/132810-83-4.gif) |
Blonanserin iMpurity |
132810-83-4 |
C23H30FN3 |
![Deferasirox iMpurity](../cas/20210111/gif/1688656-83-8.gif) |
Deferasirox iMpurity |
1688656-83-8 |
C42H28N6O8S |
![Lercanidipine iMpurity](../cas/20210111/gif/320750-19-4.gif) |
Lercanidipine iMpurity |
320750-19-4 |
C37H43N3O6 |
![AMpicillin EP IMpurity J](../cas/20200515/gif/6489-58-3.gif) |
AMpicillin EP IMpurity J |
6489-58-3 |
C13H20N2O4S |
![Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-BenzenediacetaMide)](../cas/20211123/gif/120512-04-1.gif) |
Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-BenzenediacetaMide) |
120512-04-1 |
C17H23N5O2 |
![CefathiaMidine Lactone](../cas/20180808/gif/905712-2d22-3.gif) |
CefathiaMidine Lactone |
905712-22-3 |
C17H24N4O4S2 |
![Cinacalcet IMpurity 9](../cas/20211123/gif/802918-36-1.gif) |
Cinacalcet IMpurity 9 |
802918-36-1 |
C22H24F3N |
![Doxorubicin IMpurity B](../cas/20210111/gif/106401-68-7.gif) |
Doxorubicin IMpurity B |
106401-68-7 |
C29H34BrNO11 |
![EzetiMibe IMpurity B](../) |
EzetiMibe IMpurity B |
|
|
![Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one]](../cas/20150408/gif/cb42674319.gif) |
Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] |
1449785-88-9 |
C10H7F2N3O |
![HydroxyMethylidene thione](../cas/20150408/gif/1320360-86-8.gif) |
HydroxyMethylidene thione |
1320360-86-8 |
C15H18N4OS |
![Lansoprazole IMpurity I](../) |
Lansoprazole IMpurity I |
|
|
![Lapatinib IMpurity 10](../cas/20200515/gif/1152131-73-1.gif) |
Lapatinib IMpurity 10 |
1152131-73-1 |
C26H17ClFN3O4 |
![Metronidazole IMpurity D](../) |
Metronidazole IMpurity D |
|
|
![3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide](../cas/20200119/gif/cb42715458.gif) |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
![Tigecycline](../) |
Tigecycline |
|
|
![1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione](../cas/20150408/gif/1496551-72-4.gif) |
1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
1496551-72-4 |
C10H13ClN2O5 |
![1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-](../cas/20180808/gif/1020414-33-8.gif) |
1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
1020414-33-8 |
C22H25ClF3N |
![4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine](../cas/20150408/gif/cb42716066.gif) |
4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
1823431-32-8 |
C7H9Cl2N3OS |
![Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester](../cas/20150408/gif/866551-95-3.gif) |
Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester |
866551-95-3 |
C20H27NO7 |
![4',6'-Dinitro-2'-phenoxymethanesulfonanilide](../cas/20150408/gif/51765-56-1.gif) |
4',6'-Dinitro-2'-phenoxymethanesulfonanilide |
51765-56-1 |
C13H11N3O7S |
![5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride](../cas/20150408/gif/33778-93-7.gif) |
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride |
33778-93-7 |
C20H26ClNO4 |
![Blonanserin Impurity I](../) |
Blonanserin Impurity I |
|
|
![25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol](../cas/20150408/gif/1246302-95-3.gif) |
25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol |
1246302-95-3 |
C27H40D6O2 |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](../cas/20200611/gif/1564265-95-7.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-95-7 |
C18H25N3O2 |
![(1S,5R,6R)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester](../cas/20150408/gif/876014-27-6.gif) |
(1S,5R,6R)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester |
876014-27-6 |
C9H12O4 |
![(3R,5R)-Rosuvastatin Lactone](../cas/20180808/gif/1422954-11-7.gif) |
(3R,5R)-Rosuvastatin Lactone |
1422954-11-7 |
C22H26FN3O5S |
![(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine](../cas/20150408/gif/cb42724560.gif) |
(S)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine |
1867177-06-7 |
C9H13N3OS |
![EMpagliflozin iMpurity 10](../cas/20200611/gif/2069942-68-1.gif) |
EMpagliflozin iMpurity 10 |
2069942-68-1 |
C32H37ClO12 |
![EMpagliflozin iMpurity 15](../) |
EMpagliflozin iMpurity 15 |
|
|
![(S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione](../cas/20150408/gif/cb42731188.gif) |
(S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione |
668269-51-0 |
C25H28N8O2 |
![ibrutinib iMpurity B](../) |
ibrutinib iMpurity B |
|
|
![Sunitinib iMpurity A](../) |
Sunitinib iMpurity A |
|
|
![Sunitinib iMpurity F](../) |
Sunitinib iMpurity F |
|
|
![(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one](../cas/20150408/gif/cb42735580.gif) |
(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-06-5 |
C24H21F2NO3 |
![Betamethasone EP Impurity J](../cas/20180702/gif/18383-24-9.gif) |
Betamethasone EP Impurity J |
18383-24-9 |
C22H30O4 |
![Cefazedone Related Impurity 10](../cas/20211123/gif/18884-65-6.gif) |
Cefazedone Related Impurity 10 |
18884-65-6 |
C10H12N2O5S |
![Etoricoxib Impurity 8](../cas/20200611/gif/1421227-97-5.gif) |
Etoricoxib Impurity 8 |
1421227-97-5 |
C22H20N2O4S |
![Mupirocin Impurity E](../cas/20180702/gif/cb42741868.gif) |
Mupirocin Impurity E |
|
C26H44O9 |
![Phenylephrine Impurity 1](../cas/20180702/gif/cb42741893.gif) |
Phenylephrine Impurity 1 |
|
C9H13NO2 |
![Rupatadine Impurity B](../cas/20200611/gif/156523-04-5.gif) |
Rupatadine Impurity B |
156523-04-5 |
C26H24ClN3O |
![Theophylline Impurity 1](../cas/20180702/gif/5614-53-9.gif) |
Theophylline Impurity 1 |
5614-53-9 |
C9H10N4O3 |
![Venlafaxine N-Dimer](../cas/20211123/gif/1187545-61-4.gif) |
Venlafaxine N-Dimer |
1187545-61-4 |
C32H48N2O4 |
![ent-Ivabradine Hydrochloride](../cas/20180808/gif/148849-68-7.gif) |
ent-Ivabradine Hydrochloride |
148849-68-7 |
C27H37ClN2O5 |
![Sofosbuvir metabolites GS566500](../cas/20180808/gif/1233335-78-8.gif) |
Sofosbuvir metabolites GS566500 |
1233335-78-8 |
C13H19FN3O9P |
![Ondansetron impurity G (PhEur)](../cas/20211123/gif/99614-04-7.gif) |
Ondansetron impurity G (PhEur) |
99614-04-7 |
C17H18ClN3O |
![4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester](../cas/20180808/gif/1421312-34-6.gif) |
4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester |
1421312-34-6 |
C18H15NO4 |
![2-[(4-METHYLPHENOXY)METHYL]BENZOIC ACID](../structurefile/cb4281380.gif) |
2-[(4-METHYLPHENOXY)METHYL]BENZOIC ACID |
728-97-2 |
C15H14O3 |
![Ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate](../cas/20180703/gif/cb42920085.gif) |
Ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate |
2124269-41-4 |
C16H29N5O4 |
![2-AMINO-3,5-DIBROMOBENZENE-1-CARBOHYDRAZIDE](../cas/gif/97096-13-4.gif) |
2-AMINO-3,5-DIBROMOBENZENE-1-CARBOHYDRAZIDE |
97096-13-4 |
C7H7Br2N3O |
![Trityl losartan](../cas/gif/133909-99-6.gif) |
Trityl losartan |
133909-99-6 |
C41H37ClN6O |
![4-BROMOMETHYLBIPHEBYL-2'-CARBOXYLIC ACID](../structurefile/cb4302342.gif) |
4-BROMOMETHYLBIPHEBYL-2'-CARBOXYLIC ACID |
150766-86-2 |
C14H11BrO2 |
![Letrozole Impurity](../) |
Letrozole Impurity |
|
|
![Alogliptin Impurity C](../cas/20200611/gif/1108731-49-2.gif) |
Alogliptin Impurity C |
1108731-49-2 |
C20H23N5O3 |
![Parecoxib Impurity J](../) |
Parecoxib Impurity J |
|
|
![6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one](../cas/20180702/gif/cb43038765.gif) |
6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one |
|
C38H40N4O4S |
![Atracurium Impurity F](../) |
Atracurium Impurity F |
|
|
![Linagliptin Impurity J](../) |
Linagliptin Impurity J |
|
|
![Linagliptin Impurity Q](../) |
Linagliptin Impurity Q |
|
|
![(R)-2-(((1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)-4-fluorobenzonitrile](../cas/20180702/gif/cb43042201.gif) |
(R)-2-(((1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)-4-fluorobenzonitrile |
|
C26H24F2N6O2 |
![Rosuvastatin Calcium Impurity](../) |
Rosuvastatin Calcium Impurity |
|
|
![Canagliflozin Monoacetyl Impurity](../) |
Canagliflozin Monoacetyl Impurity |
|
|
![Etoricoxib Impurity 13](../cas/20200611/gif/1817735-82-2.gif) |
Etoricoxib Impurity 13 |
1817735-82-2 |
C25H20ClN3O3S |
![Mirabegron Impurity 11](../cas/20200611/gif/1684452-85-4.gif) |
Mirabegron Impurity 11 |
1684452-85-4 |
C21H24N4O2S |
![Riociguat Impurtiy 2](../) |
Riociguat Impurtiy 2 |
|
|
![Topiroxostat Impurity 9](../cas/20200611/gif/577778-82-6.gif) |
Topiroxostat Impurity 9 |
577778-82-6 |
C13H8N6O |
![Vonoprazan Impurity F](../) |
Vonoprazan Impurity F |
|
|
![Vortioxetine Impurity 15](../cas/20210305/gif/2099147-02-9.gif) |
Vortioxetine Impurity 15 |
2099147-02-9 |
C28H34N4S2 |
![Dapagliflozin Impurity H](../) |
Dapagliflozin Impurity H |
|
|
![Dapoxetine Impurity C](../) |
Dapoxetine Impurity C |
|
|
![Eltrombopag Impurity 4](../) |
Eltrombopag Impurity 4 |
|
|
![Iodixanol Impurity](../) |
Iodixanol Impurity |
|
|
![Levothyroxine EP Impurity B](../cas/20180808/gif/1628720-66-0.gif) |
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
![Ribavirin Imp. EP)](../) |
Ribavirin Imp. EP) |
|
|
![Sertraline EP Impurity](../cas/20180702/gif/cb43050598.gif) |
Sertraline EP Impurity |
|
C17H17Cl2N |
![Vildagliptin Related Compound G](../cas/20200515/gif/1616662-84-0.gif) |
Vildagliptin Related Compound G |
1616662-84-0 |
C12H20N4O3 |
![3-ethyl 5-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate](../cas/20180702/gif/158151-92-9.gif) |
3-ethyl 5-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
158151-92-9 |
C22H29ClN2O5 |
![Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate](../cas/20180703/gif/1234321-81-3.gif) |
Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate |
1234321-81-3 |
C13H12F3NO3 |